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Abstract
Importance of the field—Microneedles are small-scale devices that are finding use for
transdermal delivery of protein-based pharmacologic agents and nucleic acid-based pharmacologic
agents; however, microneedles prepared using conventional microelectronics-based technologies
have several shortcomings, which have limited translation of these devices into widespread clinical
use.
Areas covered in this review—Two photon polymerization is a laser-based rapid prototyping
technique that has been recently used for direct fabrication of hollow microneedles with a wide variety
of geometries. In addition, an indirect rapid prototyping method that involves two photon
polymerization and polydimethyl siloxane micromolding has been used for fabrication of solid
microneedles with exceptional mechanical properties.
What the reader will gain—In this review, the use of two photon polymerization for fabricating
in-plane and out-of-plane hollow microneedle arrays is described. The use of two photon
polymerization-micromolding for fabrication of solid microneedles is also reviewed. In addition,
fabrication of microneedles with antimicrobial properties is discussed; antimicrobial microneedles
may reduce the risk of infection associated with formation of channels through the stratum corneum.
Take home message—It is anticipated that the use of two photon polymerization as well as two
photon polymerization-micromolding for fabrication of microneedles and other microstructured drug
delivery devices will increase over the coming years.
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1. Overview of the Market
Nucleic acid- and protein-based pharmacologic agents are finding greater use in the treatment
of cancer, diabetes mellitus, and other chronic medical conditions. Oral, sublingual, or rectal
delivery are the most appealing routes of administration due to the fact that doses can be
administered by the patient. In addition, no painful or complicated techniques are necessary
[1]. Unfortunately, many nucleic acid- and protein-based pharmacologic agents cannot be
administered in enteral form due to pH driven molecular degradation or first-pass metabolism
by the liver [2]. Transdermal patches have found increasing use in recent years for delivery of
hormones (e.g., estrogen), analgesic agents (e.g., fentanyl), as well as various other
pharmacologic agents; however, charged, polar, or large pharmacological agents cannot be
delivered using transdermal patches because these agents cannot pass through an intact stratum
corneum [3–5]. The stratum corneum is the outermost 15 µm thick layer of the epidermis,
which contains nonviable keratinized cells and serves as a barrier to pharmacologic agent
transport [6]. Transport of pharmacologic agents through the stratum corneum may be
enhanced through the use of chemical penetration enhancers, electroporation, iontophoresis,
and sonophoresis; however, these techniques have not seen widespread clinical use due to
issues such as tissue irritation or limited effectiveness [1,7].
Nucleic acid- and protein-based agents are commonly delivered to subcutaneous tissues,
muscle tissues, and veins by means of subcutaneous, intramuscular, and intravenous injections;
these routes of administration avoid diffusion- and enzyme-related barriers. For example,
insulin is a 51 amino acid residue, two-chain protein hormone that promotes glucose storage
in the liver as well as in other body locations. Insulin cannot be orally delivered since it is either
degraded by proteolytic enzymes in the gastrointestinal tract or metabolized in the liver. In
addition, insulin also cannot be delivered using transdermal patches because it exhibits a
relatively high molecular weight (5808 Da). Insulin is commonly delivered by means of
subcutaneous injection [8,9]. However, this route of administration is associated with trauma
at the injection site as well as pain.
Microneedles are miniaturized lancet-, thorn-, or hypodermic needle-shaped devices that
exhibit at least one dimension less than 500 µm; these devices may be used to create pores in
the stratum corneum layer of the epidermis. By creating pores in the 15 µm thick stratum
corneum layer, delivery of pharmacologic agents into deeper layers of the epidermis and the
papillary dermis is enabled [10,11]. Capillaries in the papillary dermis facilitate systemic
absorption of pharmacologic agents. Pain to the patient may be minimized if microneedles do
not interact with Meissner's corpuscles, Pacinian corpuscles, and nerve endings located within
the dermis [12]. Trauma and tissue damage at the injection site are also minimized due to the
small size of these devices; this property is especially appealing for patients with diabetes and
other medical conditions who require frequent injections [13]. In addition, no specialized
medical training or supervision is required for use of microneedles. Microneedles were shown
to provide steady and rapid reductions in blood glucose levels in diabetic hairless rats;
subcutaneous injection and microneedle delivery provided similar reductions in blood glucose
levels [14].
Microneedle-based drug delivery mechanisms fall under three categories: (a) applying a
microneedle to the skin in conjunction with another transdermal drug delivery technique (e.g.,
a transdermal patch); (b) coating a solid microneedle with a pharmacologic agent; and (c)
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infusing a liquid pharmacologic agent through the bore of a hollow microneedle. Pore
formation and topical application have been performed to deliver a number of pharmacologic
agents, including oligonucleotides, nucleic acids, and quantum dots [15–17]. Coated
microneedles have been used for several classes of pharmacologic agents, including barium
sulfate, bovine serum albumin, calcein, desmopressin, and plasmid deoxyribonucleic acid
[18,19]. In coated microneedle devices, the total amount of pharmacologic agent that can be
delivered is determined by the surface area of the needle/patch assembly [20]. Since transport
is controlled by diffusion, complex dosing (e.g., pulsatile dosing) is not possible. Microneedles
with hollow bores may enable pressure-based delivery or diffusion-based delivery of
pharmacologic agents to be maintained over an extended period of time. Devices containing
microneedles and microfluidic pump systems may be used for controlled dosing of
pharmacologic agents [5,21–22,23–24]. In addition, microneedles may be used for both drug
delivery and fluid extraction by reversing the direction of fluid transport. For example,
biosensors containing hollow microneedle patches may be used for blood sampling [21,23].
These microneedle-based sensors are being considered for monitoring of chronic medical
conditions that require frequent blood sampling, including monitoring of blood glucose levels
in diabetes mellitus patients [6,22]. Microneedles may be integrated with micropumps and
biosensors to provide blood sampling as well as drug delivery for treatment of chronic disease.
For example, patients with diabetes mellitus may be treated using transdermal "artificial
pancreas" devices that provide continual blood glucose monitoring and insulin delivery;
maintenance of blood glucose levels within the narrow euglycemic range would minimize
ophthalmic, cardiovascular, nephrologic, and neurologic complications for these patients.
Microneedles have unique advantages for delivery of vaccines associated with high cost and
limited availability, including vaccines for influenza viruses. Clinical studies by Belshe et al.
and Kenney et al. have shown that intradermal administration of influenza vaccine enables use
of reduced doses in comparison with conventional intramuscular administration [25,26]. For
example, Belshe et al. demonstrated that intradermal injection provides vigorous antibody
responses with reduced doses for individuals between 18 years of age and 60 years of age;
serum antibody responses for individuals who received intradermal injections (dose=6 µg of
hemagglutinin for each antigen) and individuals who received intramuscular injections
(dose=15 µg of hemagglutinin for each antigen) did not significantly differ [25]. Kenney et al.
showed that intradermal administration of influenza vaccine (dose≥3 µg of hemagglutinin per
strain) provided seroprotection and seroconversion rates that were similar to or better than
those provided by intramuscular administration (dose≥15 µg of hemagglutinin per strain)
[26]. The use of reduced doses, which is known as dose sparing, may enable the number of
vaccine doses that are provided to a population using a given amount of vaccine to be
maximized. Kim et al. attributed the improved immunogenic response provided by intradermal
administration to antigen-presenting cell (e.g., dendritic cell) interactions with local lymph
nodes [27].
Alarcon et al. demonstrated intradermal delivery administration of influenza vaccines using
microneedles; several vaccines, including a whole inactivated influenza virus, a plasmid DNA
encoding the influenza virus hemagglutinin, and a trivalent split-virion human vaccine, were
examined using a rodent model [28]. They showed that microneedle delivery of the trivalent
split-virion human vaccine for the H1N1 strain of the influenza virus provided at least ten-fold
dose sparing compared with conventional intramuscular delivery. Zhu et al. examined solid
metal microneedle arrays that were coated with inactivated influenza virus A using a rodent
model [29]. They demonstrated that microneedle administration provided antibody responses
similar to conventional intramuscular administration against influenza virus. Kim et al.
evaluated delivery of trehalose-stabilized influenza vaccine using a microneedle patch in a
rodent model [27]. They showed that microneedle vaccination was better than intramuscular
vaccination for imparting protective immunity. In addition, the trehalose-stabilized
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microneedle vaccine elicited a stronger antibody response than the conventional unstabilized
vaccine. Ding et al. demonstrated the use of cholera toxin and diphtheria toxoid as adjuvants
for delivery of influenza subunit vaccine through microneedle array-treated skin in a rodent
model. In a recent clinical study [30], Van Damme et al. carried out a prospective, randomized
trial involving healthy adults to compare the immunogenicity of a low-dose intradermal
influenza vaccine delivered by means of a microneedle device with that of a conventional
intramuscular influenza vaccine delivered by means of a conventional hypodermic needle
[31]. They showed that low-dose intradermal vaccination provided immunogenic responses
similar to full-dose intramuscular vaccination.
Several investigators, including Bal et al., Haq et al., and Sivamani et al., have examined
clinical use of microneedles [32–34]. Haq et al. compared the sensory response to skin
penetration by 180 µm wet-etch silicon microneedles, 280 µm wet-etch silicon microneedles,
and hypodermic needles [32]. Pain intensity was evaluated using a visual analogue scale,
sensory perception was evaluated using an adapted McGill Pain Questionnaire, and skin
penetration was evaluated using external staining as well as trans-epidermal water loss
measurements. They showed that application of microneedles was associated with less pain
than application of hypodermic needles. In addition, they demonstrated that resealing of
channels created by microneedle penetration took place within 8–24 hours. Bal et al. examined
transepidermal water loss, skin redness, blood flow, and pain sensation on ventral forearm skin
after microneedle penetration [33]. A positive correlation between microneedle length and
several parameters, including transepidermal water loss, skin redness, and blood flow, was
observed. Microneedles were shown to disrupt the stratum corneum barrier layer with an
absence of pain. Minimal skin irritation was noted after microneedle penetration; however, the
duration of skin irritation did not exceed two hours. Sivamani et al. described the use of
symmetric and pointed microneedle arrays for injection of methyl nicotinate into the volar
forearm skin of human volunteers [34]. Microneedle penetration was associated with a pressure
sensation; on the other hand, no pain was observed. They demonstrated that microneedle arrays
were effective in enhancing methyl nicotinate delivery through the stratum corneum.
Over the past several decades, microneedles have been prepared using technologies that
originated in the microelectronics and glassware industries. Many of these techniques have
inherent limitations in terms of fabricating microneedles that exhibit large wall thicknesses as
well as other fracture-resistant geometries. The concept of using miniaturized devices for
transdermal drug delivery was originally developed approximately fifty years ago. In 1959,
Wagner described the concept of using microneedle devices for transdermal drug delivery
[35]. Methodologies for preparation of glass microneedles by hand pulling glass pipettes with
a micropipette puller have been widely available for several decades (Figure 1c) [36–37]. These
devices have been generally utilized in laboratory-based applications due to the fact that they
exhibit poor fracture properties. In addition, preparation of glass microneedles by hand is an
expensive, time-consuming process [37]. Approximately one decade ago, Prausnitz and
colleagues began utilizing processes that originated in the microelectronics industry in order
to fabricate microneedles for transdermal drug delivery [11]. For example, Henry et al.
described fabrication of silicon microneedle arrays by mans of reactive ion etching. Since that
time, silicon microneedles have been fabricated by Shikida et al., Wilke et al., Cromier et al.,
Griss et al., Roxhed et al., Gardeniers et al., Ji et al., and Stoeber et al. using microelectronics-
based fabrication techniques such as wet etching, reactive ion etching, and deep reactive ion
etching [18,38–45]. Images of microneedles produced by etching of silicon are shown in Figure
1(a) and Figure 1(b). Wet etching is an isotropic process that involves selective chemical
etching of silicon by means of a photo-patterned mask [38–40]. The geometries of microneedles
prepared using etching processes are limited to radially symmetrical structures; a wide variety
of simple geometric shapes such as pyramids, cones, and cylinders may be fabricated [41–
45]. In addition, these techniques provide poor control over microneedle aspect ratio.
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Furthermore, reactive ion etching and deep reactive ion etching processes are line-of-sight
methods that cannot create complex shapes, including overhanging structures [41–45].
Numerous factors have limited the commercial viability of microneedles prepared using
microelectronics-based fabrication techniques. For example, processing of microneedles using
reactive ion etching involves high costs [46]. Silicon etching requires the use of costly
cleanroom facilities, expensive equipment, as well as hazardous waste services for handling
toxic chemicals [47]. Reactive ion etching techniques are commonly used for processing silicon
as well as other semiconductor materials. Studies involving monolayer-forming Caco-2 cells
of human origin have shown that silicon, specifically silicon doped with p-type materials, is
fully biocompatible [48]. However, single crystal silicon as well as other brittle materials
commonly used in microelectronics-based fabrication techniques exhibit low fracture
toughness, absence of ductility, and low strain tolerance; large variations in fracture strength
are commonly observed in these materials [49–51]. For example, silicon is brittle at room
temperature; at low temperatures, crack tips in silicon propagate in the absence of dislocations
[47]. The mechanical properties of silicon as well as other brittle materials commonly used
microelectronics-based fabrication techniques are affected by surface roughness as well as
other surface defects (e.g., etching damage).
Another microelectronics-based fabrication technique that has been used for preparing
microneedles involves the use of photolithography in combination with patterned photoresist
masks. In this technique, a photoresist is patterned onto the surface; unprotected material is
subsequently removed using X-ray exposure or using other methods [52–53]. For example,
Moon et al. used a deep X-ray mask in combination with vertical deep X-ray exposure as well
as inclined deep X-ray exposure for fabrication of microneedles containing liquid conduits out
of polymethylmethacrylate, a polymer that is commonly used in ophthamology, dentistry, and
orthopedic surgery. Microneedles with base areas between 190–300 µm, shaft lengths between
750–1000 µm, and tip angles between 15°–20° were fabricated by altering the inclined angle
as well as the mask-substrate gap. Masks for microneedles with 70–100 µm conduit diameters,
400–600 µm lengths, as well as variety of shapes, including arrow-like, rounded, and triangular
geometries, were fabricated. Although this method allows microneedles to be fabricated using
a wide variety of materials, several shortcomings remain. Photolithography-based
microfabrication techniques such deep x-ray lithography require costly processing equipment
as well as cleanroom facilities. In addition, material is only removed along the “line of sight”
of the etchant; this parameter places a significant constraint on the microneedle geometry.
Geometrical parameters, including radius of curvature and length, are limited by the aspect
ratio of the deep reactive ion etching step. Overhangs and other complex features are difficult
to produce. In addition, spacing between microneedles is restricted by the incidence angle of
the etchant [52].
Martanto et al. and Gill et al. have described fabrication of solid metallic microneedles arrays
through infrared laser ablation of two-dimensional patterns. In their study, an infrared laser
was used to ablate a two-dimensional pattern corresponding to the needle shape on a stainless
steel sheet. The sheet was subsequently bent at an angle of 90° out of the plane of the sheet in
order to create a three-dimensional structure. Martanto et al. described fabrication of 105 needle
arrays containing 1 mm long needles from stainless steel sheets using this technique [19,54–
57]. There are constraints on the geometries of microneedles fabricated by means of laser
ablation, since this method involves processing of microneedles in two dimensions. The third
dimension is determined by the thickness of the planar sheet. Microneedle width can be readily
varied. In addition, the walls of these microneedles always exhibit a vertical orientation. In
addition, planar laser cutting is currently limited to fabrication of solid microneedles.
Gittard et al. Page 5













Electroplating is another technique that is commonly used to fabricate metallic microneedles.
In electroplating, wires or structures created by one of the above-mentioned techniques serve
as templates. A template is coated with a thick metal layer by means of electroplating, thereby
forming a metal microneedle-shaped shell (Figure 1d). Unlike planar laser cutting,
electroplating may be used for fabrication of hollow microneedles. One method to produce
microneedles by electroplating involves electroplating a wire and then chemically removing
the wire [21–22]. The former position of the wire has become the channel of the microneedle.
For example, Kobayashi et al. electroplated platinum onto a Al–1%Si wire and subsequently
dissolved the wire in 20 wt.% NaOH solution; a platinum microneedle with a 50 µm inner
diameter was fabricated using this technique. Electroplating provides good control over the
overall microneedle geometry as well as the channel geometry. This method provides little
control over the angle of the microneedle wall; for example, the microneedle wall cannot be
easily varied over the length of the microneedle.
Multiple-step electroplating processes have been utilized by several investigators, including
Shikida et al., McAllister et al., Kim et al., and Chandrasekaran et al., for preparing
microneedles [39,46,58–59]. An electroplating-based process provides better control over
overall microneedle geometry than other microneedle fabrication process. For example,
Chandrasekaran et al. utilized a surface micromachining process for fabricating gold, nickel,
palladium, and palladium-cobalt microneedles on silicon, plastic and glass substrates. In the
first step, they deposited three metal coatings on the substrate, including a coating to promote
adhesion between the substrate and the electroplating seed layer; an electroplating seed layer;
and a coating to prevent contamination or oxidation of the electroplating seed layer. A
photoresist coating was spin-coated above these seed layers. The photoresist coating was
subsequently patterned; this patterned surface served as a micromold of the microneedle shaft
bottom wall. Gold, nickel, palladium, or palladium-cobalt coatings were subsequently
electroplated into the bottom wall micromold; nickel was coated with gold in order to reduce
interactions between nickel and biological tissues. A photoresist coating was subsequently
deposited onto the structure and patterned; this structure defined the microneedle inner lumen.
A gold coating was sputtered onto the photoresist coating; this coating served as the
electroplating seed layer during fabrication of the top shell. A photoresist coating was spin-
coated and patterned on the surface of this structure; this coating was used to prepare
microneedle shaft top walls. A palladium coating was electroplated onto this structure; this
material served as the microneedle top wall. The photoresist coatings were removed in acetone.
Many microneedles produced by mans of electropating exhibit thin walls and relatively poor
fracture resistance. For example, palladium microneedles produced by electroplating with 20°
taper angles exhibited a 50% tip failure rate [60].
Several investigators have utilized template structures to fabricate molds; these molds used for
casting of microneedles. Molds have been made from a number of materials, including metals,
hydrolytic polymers, silicon, and silicone elastomer [46,53,61–66]. Casting allows fabrication
of microneedles that are not compatible with direct microfabrication techniques. In addition,
casting is a relatively rapid process, which is compatible with many conventional
manufacturing protocols [61]. Casting appears to be the most commercially viable technique
for microneedle fabrication; however, appropriate technologies for producing master structures
need further development.
Despite these shortcomings, microneedles fabricated using microelectronics-derived processes
are currently being translated into clinical use by several companies. One company (Zosano
Pharma™, Fremont, California) recently finalized Phase II clinical trials of a microneedle
device for delivery of parathyroid hormone, which is used as a treatment for osteoporosis
[67]. Another company (Debiotech S.A. Lausanne, Switzerland) has developed a microneedle
drug delivery platform (Nanoject) that they have licensed for use. Potential uses of their device
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include delivery of pharmacologic agents; intradermal delivery of vaccines; and biological
sampling of fluids [68]. A large medical device manufacturer (Becton Dickinson, Franklin
Lakes, NJ) has extensively examined the use of microneedles for transdermal drug delivery;
they have performed preclinical and clinical activities involving microneedle delivery of over
thirty pharmacologic agents [69]. For example, Mikszta et al. utilized microneedles for
intradermal delivery of a recombinant Bacillus anthracis protective antigen to rabbit and mouse
models [70]. Microneedle-mediated intradermal delivery resulted in up to 90% seroconversion
following a single dose; on the other hand, intramuscular injection resulted in 20%
seroconversion. They demonstrated that the microneedle-treated animals developed complete
protection against aerosol-administered Bacillus anthracis spores. A major vaccine
manufacturer (Sanofi Pasteur, Paris, France) is evaluating intradermal delivery of vaccines
using the Soluvia™ microneedle-based microinjection system (Becton Dickinson, Franklin
Lakes, NJ) [71]. The European Commission recently has provided this company with approval
for intradermal delivery of seasonal influenza vaccine in European Union territory [72].
Another company (Nanopass Technologies Ltd., Nes Ziona, Israel) has developed a
microneedle-based H1N1 vaccination system that they claim will “dramatically enhance both
the effectiveness and supply of pandemic flu vaccines”; they recently completed a clinical trial
involving microneedle delivery of influenza vaccine [73]. They demonstrated that low doses
of intradermally-administered influenza vaccine provided immunogenic responses similar to
full doses of intramuscularly-administered influenza vaccine. Several patents that describe
microneedle fabrication technologies, microneedle designs, and microneedle delivery
mechanisms have been granted [74–85].
2. How the Technology Works
One promising method for microneedle fabrication that has developed in recent years is a rapid
prototyping process known as two photon polymerization. The term rapid prototyping is used
to describe additive, layer-by-layer processing of three-dimensional structures from solid,
liquid, or powder precursors. The advantages and disadvantages of two photon polymerization
as well as other microneedle fabrication techniques are provided in Table 1. It should be noted
that two photon polymerization is compatible with many photosensitive resins, which are
widely available and may be obtained at low cost. In addition, two photon polymerization can
be performed in conventional facilities. For example, two photon polymerization can
potentially be set up in a conventional clinical environment (e.g., an outpatient medical office)
for fabrication of patient-specific drug delivery devices that conform to a given patient's
anatomy and medical condition. On the other hand, many conventional microneedle fabrication
techniques require the use of clean room facilities; the energy consumption of clean room
facilities may run as high as 10,200 kW/m2 [86]. Finally, the two photon polymerization
processing rate is suitable for scaling up to high-rate commercial manufacturing.
Two photon polymerization utilizes ultrashort laser pulses for selective polymerization of
photosensitive resins into complex microscale and nanoscale structures. Polymerization of the
photosensitive resin is initiated by a process known as two photon absorption. Nearly
simultaneous absorption of two photons from a near-infrared femtosecond laser source creates
what is known as a virtual state for several femtoseconds. This electronic excitation is
analogous to that of a single photon with a higher energy [87]. The process is called non-
degenerate two photon absorption when the two photons are of different wavelengths. The
process called degenerate two photon absorption when the two photons are of identical
wavelengths [88]. Two photon absorption provides a nonlinear energy distribution, which is
centered at the focal point of the laser. Due to the nonlinear energy distribution of two photon
absorption, negligible absorption occurs except in the immediate vicinity of the focal volume
of the light beam.
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Lee et al. have examined the physical basis of two photon polymerization [89]. The energy
distribution observed in two photon absorption is a Gaussian shape, which exhibits asymmetry
in the planes of voxel width and voxel length (Figure 2a). In two photon polymerization, the
photon energy is absorbed by photoinitiator molecules within the photosensitive resin. Upon
absorption of photon energy above a given threshold, the photoinitiator molecules release free
radicals. These molecules enable free radical polymerization of monomers within the
photosensitive resin. Formation of a polymerization voxel occurs at locations where the photon
energy is above the threshold value. Unpolymerized material is subsequently washed away
using an appropriate solution. One advantage of the two photon polymerization process over
conventional stereolithography processes is that two photon polymerization allows for three-
dimensional processing of photosensitive resins; photosensitive resins used for two photon
polymerization are transparent to near-infrared light. On the other hand, conventional single-
photon stereolithography processes involve polymerization of material at the surface of the
photosensitive resin [87,89].
The desired structure is produced by selective polymerization of material along a laser trace,
which is moved in three dimensions within the resin (Figure 2b) [87]. A computer-aided design
(CAD) model of the desired structure is initially sliced into layers. Each layer is subsequently
written in the photosensitive resin by rastering the laser path in order to fill in the contour of
each layer (Figure 2c). Customized software for controlling the laser path may be used to
fabricate complicated structures such as circles or spirals [90]. Processing of the photosensitive
resin involves one of the following mechanisms: (a) by moving the photosensitive resin while
keeping the laser stationary, or (b) by moving the laser pulses within the resin using a galvano-
scanner [91–93]. Galvano-scanners may be used to direct laser-material interaction in two
dimensions; movement of the substrate may be used to adjust the depth of laser-material
interaction within the resin. The numerical aperture of the objective limits the overall
dimensions of structures fabricated using a galvano-scanner. A piezo-electric stage provides a
larger travel range; however, writing with a galvano-scanner is more rapid as well as more
accurate than writing with a piezo-electric stage. A system containing a galvano-scanner and
piezoelectric stages provides the advantages of both techniques. For example, a galvano-
scanner may be used to fabricate a single microneedle while a piezoelectric stage may be used
to translate a surface in two dimensions for fabrication of microneedle arrays [10, 91].
Two photon polymerization allows for polymerization within volumes that are smaller than
the laser wavelength [93–96]. Structures with <100 nm features have been fabricated (a) by
using photoinitiators that exhibit high initiating efficiency; (b) by controlling the incident laser
power; and (c) by modifying the laser focus scan speed [97–99]. Other factors that determine
minimum feature size include laser focus spot size, laser wavelength, and numerical aperture
[89]. The polymerization threshold energy may be modified through selection of an appropriate
photoinitiator; the other parameters may be used to alter the height of the energy distribution
and the width of the energy distribution. Since focusing is performed by passing the laser pulses
through an objective, the resolution of two photon polymerization is readily scalable through
selection of an appropriate objective. For example, a 5 × objective may be used to prepare
voxels with single-digit micrometer diameters [93]. Since there is an inverse correlation
between fabrication time and voxel size for a given structure, scalable processing may be used
to maximize processing efficiency and minimize processing costs.
Microneedles for drug delivery must be greater than 100 µm in length since the stratum
corneum is flexible. In addition, the thickness of the stratum corneum varies in thickness with
age, location, and skin condition [100]. Longer (>700 µm) microneedles may be used for
withdrawal of blood from dermal blood vessels. Several studies have examined the
relationships between microneedle geometry and fracture properties. For example, Davis et al.
demonstrated that the interfacial area of the microneedle tip and the microneedle insertion force
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exhibited a linear relationship [101]. They showed that the microneedle wall thickness was
directly related to the microneedle fracture force. In addition, they demonstrated that the
microneedle wall angle was directly related to the microneedle fracture force. They also
demonstrated that the ratio of fracture force to insertion force, also known as the safety margin,
increased as the microneedle tip radius was reduced. Aoyagi et al. also found that lower
microneedle penetration forces were associated with smaller tip angles [64]. In addition, Moon
et al. suggested that microneedles must exhibit high aspect ratio shafts, sharp as well as tapered
tips, small surface areas, and out-of-plane structures in order to meet structural requirements
[52]. Griss et al. have shown that out-of-plane microneedles, which contain flow channels that
are positioned off-center with respect to the needle tip, do not suffer from obstructions caused
by loose skin [102]. Two photon polymerization is commonly used for fabricating arrays of
microneedles. Microneedle arrays are favored over solitary microneedles since they provide a
larger surface area over which a pharmacologic agent may be delivered or a biological fluid
may be extracted. For example, microneedle arrays offer a greater probability of directly
reaching blood vessels in the dermis for extraction of biological fluids. In addition, microneedle
arrays provide redundancy in case individual needles are fractured or obstructed during
handling or insertion [103] Finally, microneedle arrays are also less susceptible to fracture if
they are exposed to shear forces since the forces are distributed over a wider area [102].
3. Two Photon Polymerization of Microneedles
In order to be compatible with two photon polymerization, a material must fulfill two
requirements. First, the material must be capable of being polymerized by means of two photon
absorption either in unmodified form or with the assistance of a photoinitiator. Second, the
material must be transparent to the wavelength of the laser [6]. Fortunately, many materials
satisfy these requirements. Materials that have been shown to be compatible with two photon
polymerization include but are not limited to SU-8 photoresist [99], methacryloxypropyl
trimethoxysilane- zirconium propoxide copolymer [90], organically modified ceramic
materials [1,77,79–80,74,91], ethoxylated (6) trimethylolpropane triacrylate [88],
polyethylene glycol diacrylate [71,88], as well as other acrylate- and methacrylate-based
polymeric materials [6].
The first microneedles directly produced by two photon polymerization were made from
Ormocer® (organically modified ceramic) materials [10]. These amorphous materials were
originally prepared by the Fraunhofer-Institut für Silicatforschung (Wurzburg, Germany) using
sol-gel processes. Ormocer® materials are prepared from urethane- and thioether (meth)-
acrylate alkoxysilane precursors. The inorganic components in Ormocer® materials crosslink
and form networks through condensation of organically modified alkoxysilane groups [104].
The organic components in Ormocer® materials crosslink through light-initiated processes as
well as other processes [104]. Interactions between the ceramic and polymer components
prevent separation of Ormocer® material into separate phases. X-ray diffraction confirmed
that Ormocer® material fabricated with two photon polymerization exhibits an amorphous
structure [10]. In addition, these interactions provide Ormocer® materials with chemical and
thermal stability. Ormocer® materials remain stable to 350° C in an oxygen atmosphere and
415° C in a nitrogen atmosphere [105]. The mechanical properties for Ormocer® materials
may be varied between those of ceramics and those of polymers by varying several parameters,
including the amount of organic network modifying elements, the amount of inorganic network
modifying elements, the spacer length that connects the organic crosslinking sites and the
inorganic crosslinking sites, and the concentration of fillers. In addition, Ormocer® materials
exhibit less shrinkage (~2%) than other sol-gel materials because of the stability of the
inorganic network and the inclusion of fillers [106]. Many other materials prepared by sol–gel
processing exhibit high (>20%) volume shrinkage during curing, network densifying, or
solvent removal steps; these processes may lead to significant mechanical stresses, cracks, as
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well as other defects. Ormocer®- based matrix components (Definite™) and Ormocer®- based
light-curable dental composites (Admira™) are presently utilized in restorative dentistry.
Carboxy-modified Ormocer® materials are also utilized as matrix materials in light-curable
glass ionomer cements [106].
In vitro assays, such as the 3{4,5-dimethylthiazol-2-yl}-2,5-diphenyltetrazolium bromide
(MTT) assay, have been used to examine cell growth on Ormocer® materials [107,108]. Live/
dead assays demonstrated that polymerized Ormocer® surfaces do not significantly impair cell
viability or growth rates for B35 neuroblast-like cells and HT1080 epithelial-like cells [10]. In
addition, the MTT assay was used to examine cell proliferation on two organically modified
ceramic materials, Ormocore® and Ormocer® US-S4 [91,109]. This assay involves the
reduction of a yellow tetrazolium salt (MTT) to a purple formazan dye by mitochondrial
succinnic dehydrogenase. Both materials were shown to support human epidermal keratinocyte
growth. No significant differences between human epidermal keratinocyte growth on
organically modified ceramic surfaces and on control surfaces were noted. These results
suggest that Ormocore® and Ormocer® US-S4 materials processed using two photon
polymerization do not impair human epidermal keratinocyte viability or growth.
Nanoindentation of Ormocer® US-S4 material provided hardness and Young’s modulus values
of ~90 MPa and ~2100 MPa, respectively [109]. Considerable viscoelastic/plastic creep as well
as viscoelastic recovery behavior were observed during testing. Park et al. suggested that
microneedles fabricated using materials with Young’s modulus values greater than ~1 GPa
exhibit fracture forces that exceed microneedle insertion forces [63,101]. Their work also
suggests that microneedles fabricated using materials with higher Young’s modulus values
may provide larger microneedle failure forces. The high hardness and modulus values observed
in Ormocer® US-S4 material may be attributed to the strong interlinkages between ceramic
and polymer components in the material.
Figure 3 contains a scanning electron micrograph of an microneedle array fabricated out of
Ormocer® organically modified ceramic material by means of two photon polymerization
[110]. The microneedles within this array exhibit excellent microneedle-to-microneedle
uniformity. Doraiswamy et al. fabricated a ten-by-ten hollow microneedle array out of
Ormocer® US-S4 material using two photon polymerization [10]. The microneedles in this
array demonstrated base diameters of 200 µm. The microneedle walls tapered linearly to sharp
tips over needle lengths of 750 µm. These microneedles demonstrated much larger wall
thicknesses than thin-walled microneedles created using conventional lithography-based
techniques. Compression testing of the microneedles against porcine skin showed that the
microneedles remained intact and did not exhibit fracture after microneedle-skin interaction.
Compression testing of Ormocer® microneedles against polytetrafluroethylene surfaces
demonstrated that Ormocer® microneedles undergo elastic and plastic deformation; the
nonlinear stress-strain behavior of the devices could be attributed to the presence of the
methacrylate groups in the Ormocer® US-S4 material. The flexibility of the two photon
polymerization process enables the geometry, size, and mechanical properties of microneedles
to be readily modified. Ovsianikov et al. fabricated in-plane hollow microneedle arrays and
out-of-plane hollow microneedle arrays (microneedle length=800 µm, microneedle base
diameter=150–300 µm) with various aspect ratios out of Ormocer® US-S4 material using two
photon polymerization [91]. Off-center microneedles were created by adjusting the position
of the bore relative to the central axis. The aspect ratio was altered by varying the diameter of
the microneedle base. The diameter of the channel was maintained at a constant value. Figure
4(a), Figure 4(b), and Figure 4(c) contain computer-aided design images of microneedles with
(a) 0 µm, (b) 1.4 µm, and (c) 20.4 µm bore-center displacement values. Figure 4(d), Figure 4
(e), and Figure 4(f) contain scanning electron micrographs of Ormocer® microneedles with
(d) 0 µm, (e) 1.4 µm, and (f) 20.4 µm bore-center displacement values. The microneedles were
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tapered linearly from the base to the tip. The length of the microneedle (800 µm) would enable
use for withdrawal of biological fluids as well as delivery of pharmacologic agents. Ripple-
like features were observed on the microneedle walls. These features were attributed to layer-
by-layer processing of the structures. The ripple-like features may be eliminated by increasing
the number of the layers used for microneedle fabrication. Compression testing of several in-
plane and out-of-plane hollow Ormocer® microneedles against porcine skin showed that these
microneedle arrays were able to porcine adipose tissue without fracture. The tips of the
microneedles exhibited bending during the compression; this elastic behavior was attributed
to the presence of methacrylate groups in the Ormocer® US-S4 material. Compression testing
of in-plane and out-of-plane hollow microneedles against polytetrafluroethylene surfaces
revealed that higher load values were required to fracture microneedles with larger base
diameter values. In addition, off-center microneedles exhibited sharp needle tips and the low
penetration threshold values. Doraiswamy et al. also used two photon polymerization to
fabricate Ormocer® microneedles with 3:1, 3.5:1 and 4:1 aspect ratios [109]. These
microneedles were fabricated by varying the microneedle length while maintaining the base
diameter of 150 µm as well as the inner channel diameter.
Microneedles with complex geometries, including rocket-like and mosquito-fascicle-like
shapes, may be fabricated using two photon polymerization. For example, microneedles with
a rocket-like shape consisting of a cylindrical shaft and support braces have been fabricated
using two photon polymerization (Figure 4a). This needle geometry exhibits relatively small
tip angle; as previously mentioned, lower microneedle penetration forces are associated with
smaller microneedle tip angles [60, 111]. Two photon polymerization has also been used for
fabrication of microneedles with biomimetic attributes. For example, the fascicle of the
mosquito exhibits sub-micrometer features that enhance skin penetration. The fascicle contains
several organs, including the hypopharynx, labrum (feeding tube), mandibles, and maxillae.
The maxillae exhibits serrated features, which facilitate skin penetration at relatively low forces
[112, 113]. Aoyagi et al. used finite element modeling as well as experimental studies to show
that the serrated tips provide enhanced stress concentrations that facilitate skin penetration
[64]. An Ormocer® mosquito-like microneedle was fabricated by means of two photon
polymerization [114, 115].Figure 5b shows a scanning electron micrograph of the Ormocer®
mosquito-like microneedle; serrated features on the microneedle tip are clearly observed.
Ormocer® microneedles fabricated using two photon polymerization have been used for
delivery of fluorescein-conjugated biotin and PEG-amine quantum dot solutions to cadaveric
porcine skin. Quantum dots are 2 nm-10 nm diameter semiconductor nanoparticles that are
composed of II–VI or III–V semiconductor materials [116]. Quantum dots demonstrate large
molar extinction coefficients and high quantum yield values; as a results, these materials
provide higher brightness than conventional fluorophores [117]. Quantum dots may be used
to detect cancer via passive mechanisms (e.g., quantum dots may be preferentially retained
within tumor cells) or active mechanisms (e.g., quantum dots may be conjugated with tumor-
specific molecules that enable attachment to tumor cells) [118–121]. These materials may not
be administered in oral form since they may be confined within the intestine, liver, kidneys,
or lungs before entering systemic circulation [122–123]. In recent work, Ormocer®
microneedles successfully created pores in the stratum corneum layer, which facilitated
transdermal administration of PEG-amine quantum dot solution [109]. Microneedles created
using two photon polymerization were shown to enable distribution of PEG-amine quantum
dot solution to deep epidermis and dermis layers of cadaveric porcine skin after sixty minutes.
Figure 6 contains DIC-fluorescence micrographs of porcine skin sections that were obtained
five minutes after fluorescein-conjugated biotin administration and sixty minutes after
fluorescein-conjugated biotin administration. The Ormocer® microneedles enabled
distribution of fluorescein-conjugated biotin to deep epidermis and dermis layers of cadaveric
porcine skin after sixty minutes. It is anticipated that microneedles with different dimensions
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may provide control over transport of pharmacologic agents into specific epidermal, dermal,
or subdermal layers.
Two photon polymerization followed by subsequent molding steps may be utilized for creating
solid microneedles as well as solid microneedle arrays [61,65,66]. The chemical, mechanical,
and physical properties of the materials used to fabricate the devices in this indirect rapid
prototyping process are conserved because these materials do not undergo two photon
polymerization processing. In addition, microneedles may be fabricated out of a broader range
of materials that are incompatible with two photon polymerization. LaFratta et al. showed that
an indirect rapid prototyping process involving photopolymerization and micromolding may
be used for fabrication of three-dimensional microscale structures [124]. Gittard et al. recently
used a two photon polymerization and polydimethyl siloxane micromolding for microneedle
fabrication [61]. Two photon polymerization was used to make a master structure, which was
subsequently used to make a negative mold from poly(dimethyl siloxane). The negative mold
was then used to cast microneedles out of photoreactive acrylate-based polymer (Envisiontec,
Ferndale, MI). The acrylate-based polymer is a water-resistant material that exhibits flexural
strength of 2,300 MPa (D790M test method), hardness of 83 Shore (D2240 test method), tensile
strength of 57.8 MPa (D638M test method), Young’s modulus of 2,400 GPa (D638M test
method), and glass transition temperature of 109° C (E1545-00 test method); it should be noted
that this material is opaque and as such may not be processed using two photon polymerization.
The solid microneedles exhibited base diameters of 150 µm and lengths of 500 µm. The
microneedle array demonstrated good microneedle-to-microneedle uniformity. In most cases,
microscale features in the microneedles were consistent with dimensions described in the
computer-aided-design file; however, some of the microneedles exhibited slight deviations
from the dimensions described in the computer-aided-design file. For example, the tips of a
small fraction of microneedles in the microneedle arrays exhibited truncated features. Twenty-
four hour MTT assays indicated that human epidermal keratinocyte growth on the acrylate-
based polymer surfaces was similar to that on control surfaces. The 5 × 5 acrylate-based
polymer microneedle arrays were able to withstand an axial load of 10 N without fracture; this
result suggests that acrylate-based polymer microneedle arrays possess suitable compressive
strength for use in transdermal drug delivery. Ex vivo studies demonstrated that microneedle
arrays successfully penetrated human stratum corneum and epidermis. Irregular ~58 µm
diameter pores were observed in the human stratum corneum and epidermis. The pores created
by the microneedles were shown to completely penetrate the stratum corneum layer and enter
the deeper epidermal layers. The pores became smaller after microneedle removal; however,
they remained open and retained capability for use as conduits for pharmacologic agents. Two
photon polymerization-micromolding provides represents a scalable approach that may be used
to create solid microneedles and microneedle arrays out of a broader range of materials than
two photon polymerization.
The two photon polymerization-micromolding process has also been used to fabricate
microneedles out of polyethylene glycol diacrylate. Once polymerized, polyethylene glycol is
a relatively stable material since hydrolytic degradation can only take place at crosslink points
[125]. Polyethylene glycol exhibits inert behavior since uncharged hydrophilic groups are
exposed in aqueous solutions. Miyano et al. demonstrated that microneedles fabricated from
polyethylene glycol were able to penetrate a living human skin model; their work suggested
that polyethylene glycol microneedles exhibited sufficient mechanical strength to be form
conduits through the stratum corneum [126]. There are minimal concerns regarding fracture
of polyethylene glycol microneedles during skin insertion since the devices undergo hydrolytic
degradation on the skin surface. Furthermore, polyethylene glycol microneedles may be
destroyed by means of boiling. Takano et al. recently demonstrated insertion of polyethylene
glycol microneedles into a wet cultured human skin model under biaxial tension; shortening
of microneedles were attributed to hydrolysis [127]. They describe placement of polyethylene
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glycol microneedles on the skin surface for extended periods of time; hydrolysis of
polyethylene glycol microneedles may allow for gradual release of pharmacologic agents.
Gittard et al. recently fabricated polyethylene glycol diacrylate microneedle arrays using
photopolymerization-micromolding, which exhibited base diameters of 150 µm, lengths of 500
µm, tip angles of 45°, and >10 µm tip diameters; good correspondence with the master structure
was observed [65]. Truncated microneedle tips as well as voids within microneedles were
observed in a small fraction of the microneedles within the microneedle arrays. These defects
were attributed to incomplete degassing of the unpolymerized polyethylene glycol solution.
Gittard et al. showed that polyethylene glycol 600 diacrylate microneedles exposed to human
platelet rich plasma did not exhibit protein aggregation or platelet aggregation [65]. Several
investigators have demonstrated that polyethylene glycol diacrylate-based materials possess
nonspecific resistance to cell adhesion and protein adsorption [128–130]. The ability of
polyethylene glycol surfaces to resist biological molecules is attributed to formation of
hydrogen bonds with water molecules; this process is enhanced by steric stabilization. Steric
stabilization is a repulsive force associated with (a) the loss in conformational freedom of
polyethylene glycol chains when proteins move closer to polyethylene glycol surfaces as well
as (b) osmotic interactions between proteins and polyethylene glycol surfaces [131]. These
properties are appealing for microneedles, since protein fouling and cell adhesion can impede
pharmacologic agent transport from microneedles to adjacent tissues.
One important factor that is limiting clinical use of microneedles and microneedle arrays is the
risk of infection. The stratum corneum prevents a variety of foreign materials, including
microorganisms, from entering the body. Pathogenic microorganisms such as Staphylococcus
aureus reside on the surface of the skin; a pore in the stratum corneum created by a microneedle
could enable microorganisms to cause local or systemic infection [132–134]. For example,
Birchall noted that the channels formed by microneedles through the stratum corneum could
increase the risk of infection [135]. He also noted that damage to the stratum coreum is transient
as well as minor in nature; however, the skin repair mechanisms in response to microneedle-
fabricated pores are not completely understood. Donnelly et al. recently examined the
movement of microorganisms across microneedle-fabricated pores by means of in vitro models
[136]. They demonstrated that pathogenic microorganisms, including Candida albicans,
Pseudomonas aeruginosa and Staphylococcus epidermidis, adhered to microneedle arrays
during insertion into excised porcine skin. It should be noted that no microorganisms entered
viable epidermis layers by means of microneedle-fabricated pores. In addition, the number of
microorganisms that penetrated microneedle-punctured Silescol® membranes was an order of
magnitude lower than the number of microorganisms that penetrated hypodermic needle-
punctured Silescol® membranes. They stated that microneedle-fabricated pores would not lead
to infections under normal circumstances in immune-competent patients; however, they
suggested that patient safety would be enhanced by manufacturing microneedles using sterile
techniques. The risk of infection associated with microneedle-fabricated pores may also be
reduced by imparting microneedles with antimicrobial properties.
Antimicrobial microneedles may be fabricated out of composite materials that contain
biocompatible polymers such as polyethylene glycol as well as conventional antimicrobial
agents such as gentamicin sulfate. Gentamicin is broad spectrum antimicrobial agent that
exhibits efficacy against Gram negative organisms as well as some Gram positive organisms.
It is commonly used for treatment of pyodermas and other skin infections; for example,
Changez et al. showed that gentamicin is active against Staphylococcus bacteria that are
commonly found on the skin [137]. Gentamicin is hydrophilic material; aqueous suspensions
containing polyethylene glycol and gentamicin may be readily produced [138]. Gittard et al.
used photopolymerization-micromolding to fabricate microneedle arrays out of a
photosensitive material containing polyethylene glycol 600 diacrylate, gentamicin sulfate, and
a photoinitiator. An agar plating assay revealed that the gentamicin-doped polyethylene glycol
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600 diacrylate microneedle inhibited growth of Staphylococcus aureus bacteria. The 26.8 mm
diameter zone of inhibition indicated that gentamicin sulfate was released from the microneedle
array. Acellular bubble-like structures were observed on the agar surface; these features were
attributed to hydrogel degradation.
Antimicrobial microneedles may also be prepared by coating microneedles with thin films of
antimicrobial materials such as silver. Silver exhibits broad-spectrum antimicrobial properties
against viruses, fungi, and bacteria (e. g., Staphylococcus aureus); this activity is attributed to
disruption of electron transport and interruption of DNA replication [139–146]. Silver also
reduces inflammatory activity as well as facilitates healing in wounds. In addition, Demling et
al. suggest that silver increases re-epithelialization compared to a conventional antimicrobial
solution [147–149]. Coatings containing antimicrobial materials may be applied to
microneedle surfaces using a physical vapor deposition process known as pulsed laser
deposition [150]. In pulsed laser deposition, a solid target is vaporized using a high energy
excimer laser; the average kinetic energies of atomic and molecular species produced by
excimer laser ablation is 100 kT-1000 kT; kT is equal to 26 meV at room temperature [151,
152]. The high energies of the laser-ablated species serve to promote adhesion of the film as
well as chemical reactions between the substrate and the film [153]. Pulsed laser deposition is
ideally suited for film deposition on polymeric substrates since many coatings may be prepared
at room temperature. For example. Gittard et al. fabricated microneedles with antimicrobial
functionality using a combination of two photon polymerization-micromolding and pulsed
laser deposition [66]. In this study, pulsed laser deposition was used to deposit silver thin films
on Ormocer® microneedle arrays, which were fabricated using two photon polymerization-
micromolding. No pinholes or other nonuniformities were noted in the silver thin films on the
silver-coated microneedles. MTT studies showed that human epidermal keratinocyte viability
on the silver-coated Ormocer® surfaces was similar to that on uncoated Ormocer® surfaces.
An agar diffusion assay was used to evaluate the antimicrobial performance of the silver-coated
Ormocer® microneedle array and the uncoated Ormocer® microneedle array. On the plate
containing the uncoated Ormocer® microneedle array, S. aureus growth was noted directly
beneath the microneedle array. On the plate containing the silver-coated Ormocer®
microneedle array, an absence of S. aureus growth beneath the microneedle array was noted.
In addition, inhibited growth was noted in the agar that surrounded the microneedle array; the
presence of a zone of inhibition suggests that silver was released into agar. The results of these
studies suggest that the photopolymerization-micromolding process may be used alone or in
combination with pulsed laser deposition to fabricate microneedles that exhibit antimicrobial
functionality.
4. Other Medical Applications of Two Photon Polymerization
Two photon polymerization may also be used to fabricated a wide variety of microstructured
and nanostructured medical devices; for example, two photon polymerization been used to
create patient-specific medical prostheses as well as scaffolds for tissue engineering.
Ovsianikov et al. utilized two photon polymerization for fabrication of ossicular replacement
prostheses, which are used to restore sound conduction in the middle ear. Three bones in middle
ear, the malleus, the incus, and the stapes, transmit sounds from the tympanic membrane to the
inner ear. Discontinuity or fixation of these bones may result in conductive hearing loss.
Conventional implants are produced in several standardized shapes and sizes; however, these
designs do not take into account individual patient anatomy. These prostheses are shaped during
implantation procedures; the intraoperative shaping process requires additional operative time.
One method for lowering the cost as well as increasing the success of ossicular replacement
prostheses involves the development of patient-specific implants. For example, imaging (e.g.,
computed tomography or magnetic resonance imaging) and analysis software may be
employed to generate an implant with an appropriate geometry and size for a particular patient
Gittard et al. Page 14













[154]. Two photon polymerization enables prosthesis to be fabricated with smaller features
than stereolithography, selective laser sintering, fused deposition modeling, or other rapid
prototyping techniques. Ovsianikov et al. demonstrated fabrication of total ossicular
replacement prostheses out of Ormocer® US-S4 material using two photon polymerization
[155]. The proestheses were similar in design to a commercially available total ossicular
replacement prostheses (Kurz Medical Inc., Dusslingen, Germany). Conical structures were
fabricated on the head of the prosthesis; these structures were intended to reduce device
migration, improve cell adhesion, and decrease the likelihood of tympanic membrane
perforation. The disk-shaped headplate of the prosthesis was intended to be placed under the
tympanic membrane. The shaft of the prosthesis connected the footplate of the stapes with the
undersurface of the tympanic membrane; this structure was intended to enable sound
conduction. An Ormocer® ossicular replacement prosthesis was placed on the footplate of the
stapes and underneath the tympanic membrane in a commercially obtained de-frozen human
head; this prosthesis was implanted and removed from the implantation site without fracture.
A total ossicular replacement prosthesis fabricated using two-photon polymerization may be
prepared with an appropriate geometry for a given patient; the prosthesis may be fabricated
with features that (a) maintain a small angle between the stapes and the prosthesis; (b) place
the prosthesis on the center of the footplate; and (c) properly align the prosthesis with respect
to the surrounding structures.
Two photon polymerization may also be used to develop artificial tissues and organs. Tissue
and organ substitutes may be created by placing living cells within three-dimensional scaffolds,
which guide cell development. The cell-seeded scaffolds are subsequently placed in
bioreactors, which provide nutrients that enable cell proliferation within the scaffolds. The cell-
seeded scaffolds are later implanted within the body, where the tissue substitutes can enable
to body to resume normal function. Rapid prototyping technologies such as two photon
polymerization hold great potential for fabrication of artificial tissues and organs with
appropriate geometries and mechanical properties for a given individual. For example,
Doraiswamy et al. fabricated three-dimensional tissue engineering scaffolds with Lego®-like
interlocking structures out of Ormocer® US-S4 material [10]. The Lego®-like interlocking
tissue engineering scaffolds contained arrays of 75 µm diameter, 20µm tall cylindrical pillar
structures on both sides of a flat Ormocer® chip. The cylindrical structures could facilitate
layer-by-layer stacking of scaffolds for development of three-dimensional tissues. Cells seeded
on these structures were oriented along the pillar walls, and were found to gradually increase
in number over time. 100% of the B35 neuroblast-like cells remained viable 48 hours after
placement on the Ormocer® substrates. The cell interaction and cell proliferation properties
of B35 neuroblast-like cells on Lego®-like interlocking tissue engineering scaffolds suggest
that Ormocer® structures fabricated using two photon polymerization may provide an
alternative to conventional scaffolds for creating multilayered artificial tissues and organs.
Proliferation of endothelial, neuroblastoma, granulosa, and keratinocyte cells on scaffolds
fabricated using two photon polymerization has also been examined [10,111,156,157]. In
addition, two photon polymerization has been used to fabricate small storage capsules on metal
stents; these structures may enable localized delivery of pharmacologic agents at the
implantation site [87].
5. Conclusions
Two photon polymerization is a novel rapid prototyping technique that may be used to fabricate
microneedles as well as microneedle arrays with a wider range of geometries than reactive ion
etching, lithography-electroforming-replication, or other conventional microelectronics-based
technologies. The two photon polymerization process relies on temporal and spatial overlap
of photons in order to achieve photopolymerization and hardening of material within highly-
localized and well-defined volumes. Our results suggest that two photon polymerization is able
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to create microneedles with a wide range of geometries, including in-plane microneedles, out-
of-plane microneedles, mosquito fascicle-shaped microneedles, and rocket-shaped
microneedles. Ormocer® microneedles fabricated using two photon polymerization penetrated
cadaveric porcine adipose tissue without fracture. Penetration of the stratum corneum layer by
Ormocer® microneedles enabled transdermal delivery of PEG-amine quantum dot solution
and fluorescein-biotin solution to the deep epidermis and dermis layers of porcine skin;
microneedles were shown to enable more rapid distribution than topical administration. A two
photon polymerization-polydimethyl siloxane micromolding process has been used to fabricate
solid microneedles out of a photo-reactive acrylate-based polymer, polyethylene glycol 600
diacrylate, and Ormocer® material; this indirect rapid prototyping process is more suitable for
large-scale processing than two photon polymerization. Solid microneedle arrays fabricated
out of photo-reactive acrylate-based polymer were successfully able to create pores in human
stratum corneum and epidermis; these arrays were able to withstand an axial load of 10 N
without fracture. Scanning electron microscopy revealed no platelet aggregation on the
surfaces of platelet rich plasma-exposed polyethylene glycol 600 diacrylate microneedles.
Antimicrobial solid microneedles were fabricated out of a photosensitive material containing
polyethylene glycol 600 diacrylate, gentamicin sulfate, and a photoinitiator using two photon
polymerization-micromolding. Antimicrobial solid microneedles were with silver coatings
were fabricated using a combination of two photon polymerization-micromolding and pulsed
laser deposition. These studies suggest that the geometry as well as the mechanical properties
of microneedles may be rapidly optimized using two photon polymerization for depth-
dependent transdermal delivery of pharmacologic agents. Several other microstructured
medical devices with unique geometries, including ossicular replacement prostheses and tissue
engineering scaffolds, have been successfully fabricated using two photon polymerization of
Ormocer® organic-inorganic hybrid materials.
6. Expert Opinion
Over the next several years, microneedles will find greater use for delivery of nucleic acid-
and protein-based pharmacologic agents that cannot be administered in enteral form. Over the
past several decades, microneedle devices have been prepared using reactive ion etching,
lithography-electroforming-replication, or other microelectronics-based fabrication
techniques. Several small and large companies are in the process of bringing their microneedle-
based devices to market for transdermal delivery of vaccines and hormones. However,
numerous factors are limited the commercial viability of microneedles prepared using
microelectronics-based fabrication techniques. In recent years, two photon polymerization has
been used to fabricate microneedles as well as microneedle arrays with a wider range of
geometries than conventional microelectronics-based technologies. Perhaps most
advantageous attribute of two photon polymerization is that it provides a high degree of control
over microneedle geometry. Microneedles must not fracture during penetration into the skin,
use, or removal from the skin. As mentioned earlier, many of the problems associated with
microneedles prepared using conventional techniques may be attributed to the fact that these
techniques have inherent limitations in terms of fabricating microneedles that exhibit large
wall thicknesses as well as other fracture-resistant geometries. In addition, two photon
polymerization is compatible with many photosensitive resins, which are widely available and
may be obtained at low cost. Furthermore, two photon polymerization can be performed in
conventional facilities; for example, two photon polymerization can potentially be set up in a
conventional clinical environment (e.g., an outpatient medical office) for fabrication of patient-
specific drug delivery devices that conform to a given patient's anatomy and medical condition.
Several commercialization and device-related challenges will need to be considered in the
coming years. For example, techniques for creating microneedles that exhibit a clinically
acceptable degree of uniformity from batch to batch must be developed. Refinement of
microneedle geometry for a given clinical application as well as a specific patient population
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is also necessary. In addition, optimization of the two photon polymerization processing rate
must be undertaken. It should be noted that a combination of two photon polymerization and
micromolding may be directly implemented in current manufacturing environments for large-
scale processing of solid microneedles as well as microneedle arrays. Furthermore, work is
needed to incorporate multiple functionalities (e.g., monitoring and treatment of multiple
chronic diseases) within a single microneedle-based device. Finally, two photon
polymerization needs to be cost competitive with conventional techniques. If these obstacles
can be overcome, two photon polymerization of microneedles as well as other drug delivery
devices may attain commercial significance over the coming decades.
7. Article highlights box
• Microneedles are miniaturized lancet-, thorn-, or hypodermic needle-shaped
devices that exhibit at least one dimension less than 500 µm; these devices may
be used to create pores in the stratum corneum layer of the epidermis.
• Over the past several decades, microneedles have been prepared using
technologies that originated in the microelectronics and glassware industries.
• Numerous factors have limited the commercial viability of microneedles prepared
using microelectronics-based fabrication techniques.
• Two photon polymerization utilizes ultrashort laser pulses for selective
polymerization of photosensitive resins into complex microscale and nanoscale
structures.
• The first microneedles directly produced by two photon polymerization were made
from Ormocer® (organically modified ceramic) materials.
• Microneedles with complex geometries, including rocket-like and mosquito-
fascicle-like shapes, may be fabricated using two photon polymerization.
• Ormocer® microneedles fabricated using two photon polymerization have been
used for delivery of fluorescein-conjugated biotin and PEG-amine quantum dot
solutions to cadaveric porcine skin.
• Two photon polymerization followed by subsequent molding steps may be utilized
for creating solid microneedles as well as solid microneedle arrays.
• Antimicrobial microneedles may be fabricated out of composite materials that
contain biocompatible polymers such as polyethylene glycol as well as
conventional antimicrobial agents such as gentamicin sulfate.
• Antimicrobial microneedles may also be prepared by coating microneedles with
thin films of antimicrobial materials such as silver.
• Two photon polymerization may also be used to fabricated a wide variety of
microstructured and nanostructured medical devices; for example, two photon
polymerization been used to create patient-specific medical prostheses as well as
scaffolds for tissue engineering.
• Two photon polymerization is a novel rapid prototyping technique that may be
used to fabricate microneedles as well as microneedle arrays with a wider range
of geometries than reactive ion etching, lithography-electroforming-replication,
or other conventional microelectronics-based technologies.
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(a) Solid silicon microneedle fabricated by reactive ion etching. (b) Solid silicon microneedle
array fabricated by reactive ion etching. (c) Hollow glass microneedle fabricated using a
micropipette puller. (d) Hollow metal microneedle fabricated by electroplating a master
structure. (e) Solid metal microneedles fabricated by laser machining and bending a metal
sheet.
(a–d) Reprinted from the Proceedings of the National Academy of Sciences, Microfabricated
needles for transdermal delivery of macromolecules and nanoparticles: Fabrication methods
and transport studies, D. V. McAllister, P. M. Wang, S. P. Davis, J. H. Park, P. J. Canatella,
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M. G. Allen, M. R. Prausnitz, Vol 100, 13755–13760, Copyright (2003) National Academy of
Sciences, U. S. A.
(e) Reprinted from Journal of Controlled Release, Vol 117, H. S. Gill, M. R. Prausnitz, Coated
microneedles for transdermal delivery, 227–237, Copyright (2007), with permission from
Elsevier.
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(a) Schematic of the two photon polymerization process. The energy distribution is a Gaussian
shape. The radius of the polymerization voxel corresponds to the position at which the energy
intensity exceeds the excitation threshold of the photoinitiator. (b) Single photon versus two
photon polymerization. Single photon polymerization is limited to the surface of a given
material. On the other hand, two photon polymerization may occur within a given material. (c)
Schematic of the rapid prototyping process. In the first step, a computer-aided design program
is used to prepare a STL format file. The STL format file is subsequently used to prepare a
layer-by-layer contour of the structure. The structure is fabricated by rastering the laser in order
to fill the area contained within the contours.
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Scanning electron micrograph of microneedle array fabricated out of Ormocer® organically-
modified ceramic material using two photon polymerization. Reprinted from American
Ceramic Society Bulletin, Vol. 88, page 22, Copyright 2009, with permission from the
American Ceramic Society.
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Computer aided design diagrams of hollow Ormocer® microneedles with (a) 0 µm, (b) 1.4
µm, and (c) 20.4 µm needle center-pore displacement. Scanning electron micrographs of
hollow Ormocer® microneedles with (a) 0 µm, (b) 1.4 µm, and (c) 20.4 µm needle center-pore
displacement. Reprinted from International Journal of Applied Ceramic Technology, Vol. 4,
Ovsianikov et al, Two photon polymerization of polymer–ceramic hybrid materials for
transdermal drug delivery, 22–29, Copyright 2007, with permission from John Wiley & Sons
Inc.
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Scanning electron micrographs of microneedles with complex geometries. (a) Scanning
electron micrograph of an Ormocer® rocket-shaped microneedle fabricated using two photon
polymerization. The small cross-sectional area minimizes the skin penetration force. (b)
Scanning electron micrograph of an Ormocer® mosquito geometry microneedle fabricated
using two photon polymerization. The serrated tip provides stress concentrations, which
decrease the skin penetration force. Image used with permission of the copyright owner (B. N.
Chichkov).
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(a) DIC-fluorescence confocal microscopy images showing administration of fluorescein-
conjugated biotin solution to porcine skin. The center columns and the right column
demonstrate that administration of fluorescein-conjugated biotin solution to deeper layers of
porcine skin was enabled by a microscale pore, which was created by an Ormocer®
microneedle. The left column shows administration of fluorescein-conjugated biotin solution
to porcine skin without microneedle enhancement. The topically administered fluorescein-
conjugated biotin solution remained on the skin surface. Top row: DIC single-channel
demonstrates stratum corneum (SC), deeper epidermis (E), and dermis (D) layers of the skin.
Bottom row: DIC-fluorescence overlay (OVR) shows distribution of fluorescein-conjugated
biotin solution within various skin layers. Scale bar equals 100 µm. (b) Scanning electron
micrograph of polyethylene glycol 600 diacrylate miconeedles after exposure to platelet rich
plasma. No protein aggregation and no platelet aggregation were observed on the polyethylene
glycol 600 diacrylate microneedles. Small, widely scattered crystals were observed on the
surface; the presence of sodium, chlorine, and phosphorus in energy dispersive X-ray
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spectroscopy data suggests that sodium chloride crystals precipitated from the platelet rich
plasma.
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Table 1
Advantages and Disadvantages of Microneedle Production Techniques
Production Technique Advantages Disadvantages
Reactive Ion Etching high resolution requires cleanroom, expensive, low throughput,
limited to silicon, geometry restrictions
Photolithography high resolution requires cleanroom, expensive, geometry
restrictions
Cutting and Bending low cost, cleanroom not required,
strong materials
only have control of two dimensions, only solid
microneedles
Two-photon Polymerization cleanroom not required, good
geometry control,
scalable resolution,
limited to photosensitive materials
Electroplating low cost, high throughput geometry controlled by master structure,
biocompatibility concerns, poor mechanical
properties due to thin walls
Casting low cost, high throughput,
compatible with many
materials
geometry controlled by master structure
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